DMK Pharmaceuticals (DMK) Restructures Executive Team
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- Oracle sets $225 billion revenue target for FY30 at investor day
- S&P Global explores potential separation of Capital IQ business
- Rivian shares slip ahead of Thursday earnings release
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Moderna stock rises on latest cancer vaccine data publication
DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
October 19, 2023 4:05 PM EDTSeth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John Dorbin assumes role of General Counsel Corporate Secretary
Appointments strengthen leadership team and provide financial and corporate expertise as the organization focuses on improving DMKs existing commercial product portfolio and reducing opioid related deaths
SAN DIEGO, Oct. 19, 2023 (GLOBE NEWSWIRE) --... More



